Zonisamide is an anticonvulsant that helps control partial seizures.
It is usually prescribed in combination with other antiseizure drugs.
It is taken by mouth once or twice daily.
Medication doses can be taken with or without food.
If you miss a dose, ask your healthcare provider for guidance.
Zonisamide, a generic anticonvulsant, is a safe and effective maintenance treatment for partial seizures. It’s commonly used in combination with other drug treatments. Doses are taken by mouth once or twice a day as a capsule or liquid, providing a reliable option for seizure control.
2.8 million people (1 in 100) in the U.S. have some form of seizure disorder. The incidence is about 150,000 new cases per year
. Of those people diagnosed with epilepsy, 46% are diagnosed with partial seizures.
Most people will take zonisamide in capsule form, which is available as a generic or under the brand name Zonegran. Those with difficulty swallowing capsules can take a liquid formulation, also available under the brand name Zonisamide.
Capsules: 25 mg, 50 mg, 100 mg
Oral suspension (liquid): 100 mg/5 mL
The Food and Drug Administration (FDA) has approved zonisamide as an adjunctive treatment for partial seizures in adults and teens 16 years of age and older. Due to medical safety concerns, healthcare providers do not prescribe zonisamide to individuals with a history of allergies to zonisamide or sulfonamide drugs.
Check our best Zonisamide prices
Zonisamide dosage chart |
|||
|---|---|---|---|
| Indication | Starting dosage | Standard dosage | Maximum dosage |
| Partial epilepsy | 100 mg daily | 100–400 mg taken as a single dose or two divided doses daily | 600 mg daily |
Partial seizures (focal seizures) affect a specific area or one hemisphere of the brain. Unlike generalized seizures, which involve both sides of the brain and often lead to loss of consciousness, partial seizures typically do not cause a complete loss of awareness. However, they may result in impairment during the episode.
2.8 million people (1 in 100) in the U.S. have some form of seizure disorder. The incidence is about 150,000 new cases per year
. Of those people diagnosed with epilepsy, 46% are diagnosed with partial seizures.
Partial seizures can be simple or complex. Most people with partial seizures have complex partial seizures, which start in one part of the brain and spread to another. People usually experience some impairment of consciousness. After the seizure, people need a few minutes or longer before they feel normal again.
A minority of people with partial seizures have simple partial seizures. These are seizures that start and stay in one part of the brain. They don’t involve changes in consciousness or require a recovery period after the seizure.
First-line treatment: The standard first-line treatments for partial seizures are the anticonvulsants carbamazepine and lamotrigine. Many people achieve seizure control with a single medication.
Refractory Seizures: If, however, seizures continue to occur (“refractory” seizures), healthcare providers will add a second drug called an adjunctive (“add-on”) or adjuvant (“helper”) treatment.
Zonisamide is one possible choice in that group of second-line adjuvant therapies.
Zonisamide's unique mechanism of action, which involves blocking the sodium and calcium channels that make nerves electrically conductive, sets it apart from other antiepileptic drugs. This unique action slows the nervous system and effectively controls seizures, with minimal side effects compared to other drugs.
As an adjunctive therapy for partial seizures, zonisamide is taken once or twice daily. Doses start at a lower dose of 100 mg daily and are gradually increased until seizures are controlled. Although the maximum recommended dosage is 600 mg daily, there is no evidence that daily doses above 400 mg are beneficial.
Standard dosage for the adjunctive treatment of partial seizures: 100–600 mg taken in a single dose or two divided doses daily
Maximum dosage for the adjunctive treatment of partial seizures: 600 mg daily
The FDA has not approved zonisamide tablets for pediatric use. However, zonisamide oral suspension is FDA-approved for use in adolescents 16 years and older. The dosages are identical to those for adults.
Standard zonisamide dosage for the adjunctive treatment of partial seizures in children 16 years of age and older: 100–600 mg taken in a single dose or two divided doses daily
Maximum zonisamide dosage for the adjunctive treatment of partial seizures in children 16 years of age and older: 600 mg daily
Healthcare providers do not need to adjust doses for people with kidney, liver, or other medical conditions. However, there is a risk of side effects in people with kidney or liver impairment. In those cases, prescribers may start with a lower dose and slowly increase it (titration). Because of the increased risk of side effects, they will monitor people with renal or hepatic impairment more closely.
Veterinarians use zonisamide as a maintenance treatment for epilepsy in dogs and cats. They may prescribe it as a stand-alone therapy or add-on treatment to other seizure medications.
Cats are usually given daily doses of 5–10 mg per kilogram of body weight. Dogs are usually prescribed 5 mg/kg daily, but veterinarians double the dose if the dog is also being given phenobarbital for seizure control.
Zonisamide is a safe drug for pets. Its side effects are minimal; however, some pets may experience drowsiness, low energy, and loss of appetite.
It's important to remember that stopping zonisamide doses without consulting a healthcare provider can be harmful. By following this advice, patients and caregivers can feel informed and responsible in managing their treatment.
General guidelines:
Take this medicine as directed.
Please read the Medication Guide included with the medicine.
Do not stop taking zonisamide doses until talking to the prescriber.
Zonisamide tablets or oral suspension can be taken with or without food.
How to take zonisamide capsules:
Swallow the zonisamide capsule whole. Do not break, chew, or open it.
Store zonisamide capsules at room temperature, protected from light and moisture.
How to take zonisamide oral suspension:
Always shake the zonisamide oral suspension to mix the medicine before measuring a dose.
Use a calibrated oral syringe or other calibrated medicine measure device. Do not use kitchen tools or tableware.
Store zonisamide at room temperature and protect it from light.
Throw away the zonisamide bottle and any remaining medicine 30 days after the bottle is opened.
Zonisamide is a long-term therapy used to control seizures. Its full therapeutic effect is usually evaluated and determined after several months of treatment.
After a single oral dose, zonisamide reaches its peak concentrations in the body within two to six hours. This process takes slightly longer if the dose is taken with food. It takes about 14 days of daily dosing before zonisamide concentrations in the body reach a steady state (where the drug maintains consistent therapeutic effects). At that point, the drug provides consistent seizure control 24 hours a day.
Zonisamide is a long-acting drug. Clinical studies indicate that its half-life in the body’s plasma is 63 hours, and in the red blood cells, it is over 100 hours. Thus, it may take over two weeks to completely clear from the body.
Ask your healthcare provider what to do if you miss a dose of zonisamide. The prescribing information and the medication guide do not provide any recommendations or instructions regarding t missed doses.
People usually take zonisamide for months or even years, but it has no if it works and doesn’t cause any side effects.
Do not stop taking zonisamide unless instructed by your healthcare provider. Suddenly, stopping zonisamide can cause severe seizures, including seizures that don’t stop (status epilepticus).
When it’s time to stop taking zonisamide, your healthcare provider will gradually reduce the dose before discontinuation. After discontinuing zonisamide, the prescriber will likely substitute another antiseizure medication. The list of possible substitutes is very long and includes drugs like gabapentin, topiramate, valproate, and pregabalin.
The maximum recommended dosage for zonisamide is 600 mg daily, though most clinicians do not exceed 400 mg daily, as higher doses have not shown additional benefits. You are likely to have side effects when doses exceed 300 mg daily.
Yes. Do not take more zonisamide than prescribed. As it will not help control seizures and may cause serious side effects. If an overdose happens, call a poison control helpline or seek medical treatment. Possible symptoms of an overdose include nausea, vomiting, sleepiness, lethargy, and frequent urination.
To avoid possible drug interactions, make sure to inform your healthcare provider about all the drugs, over-the-counter (OTC) products, and natural supplements you’re taking before you start taking zonisamide, particularly:
Anything that makes you sleepy, including sleeping pills, narcotic pain relievers, benzodiazepines, allergy medications, cannabinoid products, or alcohol
Drugs called carbonic anhydrase inhibitors, such as acetazolamide or brinzolamide
Antiepileptic drugs carbamazepine, phenobarbital, phenytoin, or primidone
The antibiotic erythromycin
The antifungal drug ketoconazole
The migraine drug dihydroergotamine
The immune suppressant cyclosporine
Do not drink alcohol when taking zonisamide. The combination can increase drowsiness and impairment, affecting your coordination and judgment.
Avoid drinking grapefruit juice when taking zonisamide, as it may affect how the drug is metabolized (broken down in the body).
Allergy medications may make you more drowsy than usual if you’re taking anticonvulsants like zonisamide.
Do not drive or engage in risky activity until you know how zonisamide affects your alertness and judgment.
If you are on a ketogenic diet, ask the healthcare provider for medical advice about continuing or modifying the diet.
Zonisamide is a risky drug to take during pregnancy. Women of childbearing age who are not pregnant should use effective birth control when taking zonisamide. The drug can cause acidosis (high acid levels), which can affect the growth and health of a fetus. Your healthcare provider performs blood tests to monitor acid levels regularly to ensure safety. Newborns may also need blood tests at birth to check for acidosis.
Zonisamide passes into breast milk, but its effect on a nursing infant is unknown. Mothers should monitor their children carefully for unusual sleepiness, lethargy, or feeding issues.
Zonisamide's most common side effects are drowsiness, dizziness, decreased appetite, concentration problems, memory problems, coordination problems (ataxia), trouble walking, irritability, agitation, and weight loss.
Serious adverse effects include kidney stones, metabolic acidosis (high acid levels), high ammonia levels, eye problems, aplastic anemia, depression, psychosis, suicidal thoughts, and severe allergic reactions or drug reactions. There is also an increased risk of heat stroke.
Talk to a doctor if you experience signs of a serious adverse reaction like:
Thinking about suicide or hurting yourself
New or worsening depression
New or worsening anxiety
Panic attacks
Severe mood swings or changes
Reckless or unusual behaviors
Excessive tiredness (fatigue)
Irregular heartbeats
Loss of appetite
Vision changes
Yellowing of the skin or eyes (jaundice)
Active epilepsy prevalence among U.S. adults is 1.1% and differs by educational level—National Health Interview Survey, United States, 2021, Epilepsy Behavior
Handling delayed or missed dose of antiseizure medications, Neurology
Partial epilepsy, StatPearls
Zonegran drug summary, Prescriber’s Digital Reference (PDR)
Zonegran zonisamide capsule prescribing information, DailyMed (NIH National Library of Medicine)
Zonisamide suspension prescribing information, DailyMed (NIH National Library of Medicine)
Zonisamide, StatPearls
Zonisamide capsule prescribing information, DailyMed (NIH National Library of Medicine)
A retrospective study of the efficacy of zonisamide in controlling seizures in 57 cats. Journal of Veterinary Internal Medicine.
Goldina Erowele, Pharm.D., MBA, is an experienced clinical pharmacist and drug information expert with specialized expertise in value based care and formulary management across academic, health systems, and public organizations. She received her Doctor of Pharmacy degree from Howard University, her Master of Business Administration from Texas Woman's University, and a PGY1 Pharmacy Practice Residency from the Veterans Affairs Medical Center in Washington, D.C. As a published author in journals such as the American Journal of Health-System Pharmacy (AJHP) and a manuscript/abstract reviewer for the American Journal of Pharmacotherapy and Pharmaceutical Sciences (AJPPS), Dr. Erowele brings a wealth of experience in medical writing/reviewing and clinical research. She is also an Adjunct Professor at Texas Southern University College of Pharmacy.
...Health education, drug info, wellness & more
Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price. This is a medical discount plan. This is NOT insurance. This program offers you the opportunity to locate providers of various types of medical services who will offer their services to you at discounted rates. The range of discounts for medical or ancillary services provided under the plan will vary depending on the type of provider and service received. You are fully responsible for paying for all health care services but will be entitled to receive a discount from those health care providers in accordance with the specific pre-negotiated discounted fee schedule. This program does not guarantee the quality of the services or procedures offered by the providers. Except for prescription drugs which you will pay directly to the pharmacy at the time of purchase, all other services received through a program provider will be charged to the credit card on file in your member account. The charge will include an administrative fee for use of the program. Towers Administrators LLC is the licensed discount medical plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services, LLC is the marketer of the discount medical plan organization including its website, singlecare.com, with its corporate office located at 99 High Street, Suite 2800, Boston, MA 02110. For additional information, including an up-to-date list of providers, or assistance with any issue related to program membership, please contact member support any time at www.singlecare.com, or by calling toll-free 844-234-3057, 24 hours, 7 days a week (except major holidays). Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Blog articles are not medical advice. They are intended for general informational purposes and are not meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, immediately call your physician or dial 911.
© 2025 SingleCare Administrators. All rights reserved
© 2025 SingleCare Administrators. All rights reserved